Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
59 participants
INTERVENTIONAL
2020-08-25
2023-09-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep Duration Required to Restore Performance During Chronic Sleep Restriction
NCT01581125
Effects of Chronic Sleep Restriction in Young and Older People
NCT00506428
Chronic Sleep Restriction
NCT01493661
Neurobehavioral Effects of Partial Sleep Deprivation
NCT02128737
Interaction of Chronic Sleep Restriction and Circadian Misalignment on Sleep and Neuro-cognitive Performance
NCT00438438
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sleep Arm 1
This will be the first of four arms of controlled sleep manipulation.
Controlled sleep
Duration and timing of sleep will be assigned and monitored in a controlled laboratory environment with controlled lighting and meals.
Sleep Arm 2
This will be the second of four arms of controlled sleep manipulation.
Controlled sleep
Duration and timing of sleep will be assigned and monitored in a controlled laboratory environment with controlled lighting and meals.
Sleep Arm 3
This will be the third of four arms of controlled sleep manipulation.
Controlled sleep
Duration and timing of sleep will be assigned and monitored in a controlled laboratory environment with controlled lighting and meals.
Sleep Arm 4
This will be the fourth of four arms of controlled sleep manipulation.
Controlled sleep
Duration and timing of sleep will be assigned and monitored in a controlled laboratory environment with controlled lighting and meals.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Controlled sleep
Duration and timing of sleep will be assigned and monitored in a controlled laboratory environment with controlled lighting and meals.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 18.5-29.9, with consideration of BMIs 30-34.9.
Exclusion Criteria
* Color blindness
* Recent nightwork, shiftwork, or travel across greater than two time zones
* Pregnant or within 6 months post-partum
20 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brigham and Women's Hospital
OTHER
Civil Aerospace Medical Institute
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hilary Uyhelji, PhD
Role: PRINCIPAL_INVESTIGATOR
FAA Civil Aerospace Medical Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brigham and Women's Hospital
Boston, Massachusetts, United States
FAA Civil Aerospace Medical Institute
Oklahoma City, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GEN10025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.